Squamous cell carcinoma of the bladder: poor response to neoadjuvant chemotherapy

ConclusionsAnalysis of a national tumor registry suggests a lack of overall survival benefit for NAC with localized, muscle invasive SCC of the bladder. Further research directed at chemotherapy regimens for SCC is needed to optimize treatment and improve survival outcomes.
Source: International Journal of Clinical Oncology - Category: Cancer & Oncology Source Type: research